期刊文献+

靶向白介素-1α基因沉默的Hela229稳定细胞系的构建

Establishment of Hela229 Stable Cell Lines with Interleukin-1 Alpha Gene Knockdown
下载PDF
导出
摘要 目的:构建针对IL-1α基因的shRNA表达载体,筛选能够抑制Hela229细胞内源性IL-1α表达的shRNA,建立无内源性IL-1α表达的Hela229稳定细胞系。方法:根据shRNA的设计原则,以IL-1αcDNA oligo为模板设计一段21 bp核苷酸目标序列,构建成siRNA的DNA模板并克隆到shRNA表达载体pRNAT-U6.1/Neo中,获得靶向抑制IL-1α基因的重组shRNA质粒,转染Hela229细胞,经G418筛选后获得单克隆稳定细胞株,用ELISA方法在蛋白水平上检测IL-1α基因的沉默效果。结果:经酶切鉴定和测序分析确定IL-1α-shRNA重组质粒构建正确,ELISA筛选出能够显著抑制内源性IL-1α表达的shRNA,获得沉默内源性IL-1α表达的单克隆稳定的Hela229细胞株。结论:靶向IL-1α基因的重组shRNA表达质粒可显著抑制Hela229细胞内源性IL-1α的表达,成功构建靶向IL-1α基因沉默的Hela229稳定细胞系。 Objective:Constructing IL-1α gene targeted short hairpin RNA interference expression vector,which can inhibit the endogenous expression of IL-1α of Hela229 cells,to establish the endogenous IL-1α gene knockdown stable cell line.Method:Design a 21 bp target nucleotide sequence according to the principle of shRNA desigation,clone the DNA template of siRNA into the shRNA expression vector pRNAT U6.1/Neo,gain the inhibition of IL-1α gene recombinant shRNA expression plasmid,transfect the plasmid into Hela229 cells.Monoclonal stable cell lines was established after screening by G418.Detect the IL-1α supression effect at the protein level via the method of ELISA.Results:IL-1α-shRNA carrier recombination were determined the correct construction through the enzyme identification and sequencing analysis.ELISA results showed that the restructuring of the IL-1α-shRNA expression vector can significantly inhibit the expression of endogenous IL-1α of Hela229 cells.Conclusion:Targeted IL-1α gene recombinant shRNA expression plasmid can significantly inhibit the expression of endogenous IL-1 α of Hela229 cells.Successfully established the Hela229 stable cell line with IL-1α gene knockdown.
出处 《激光生物学报》 CAS CSCD 2013年第5期441-446,440,共7页 Acta Laser Biology Sinica
基金 国家自然科学基金资助项目(81071403)
关键词 IL-1Α HELA229细胞 SHRNA IL-1α Hela229 cell shRNA
  • 相关文献

参考文献14

  • 1CHRIS B, ELIZABETH H, HUANG M, et al. Short hairpin RNA ( shRNA ) : design, delivery, and aseessment of gene knockdown [ J]. Methods Mol Biol, 2010, (629) : 141-158.
  • 2APTE R N, DOTAN S, ELKABETS M, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions [ J]. Cancer Metastasis, 2006, ( 25 ) : 387-408.
  • 3APTE R N, VORONOV E. Is interleukin-1 a good or bad ' guy' in tumor immunobiology and immunotherapy? [J]. Immu- nol, 2008, (222) :222-241.
  • 4PELEG R, YARON C, OFER G, et al. IL-1 α and IL-1β re- cruit different myeloid cells and promote different stages of sterile inflammation[ J]. Immunol, 2011, (187) :4835-4843.
  • 5BANDO M, HIROSHIMA Y, KATAOKA M, et al. Interleukin- 1 alpha regulates antimicrobial peptide expression in human kera- tinocytes[ J]. Immunol Cell Biol, 2007, 85 (7) :532-540.
  • 6HURGIN V, NOVICK D, WERMAN A, et al. Antiviral and immunoregulatory activities of IFN-gamma depend on eonstitu- tivelyexpressed IL-lalpha[ J]. Proc Natl Acad Sci USA, 2007, 104(12) :5044-5049.
  • 7WERMAN A, WERMAN R, WHITE R, et al. The precursor form of IL-1 ct is an intracrine proinflammatory activator of tran-scription[ J]. Proc Nati Acad Sci USA,2004, 101(8):2434-2439.
  • 8CHENG W, SHIVSHANKAR P, ZHONG Y, et al. Intracellular interleukin-1 alpha mediates interleukin-8 production induced by chlamydia traehomatis infection via a mechanism independent of type I interleukin-1 receptor[ J]. Infect Immun, 2008, 76 (3) : 942-951.
  • 9KOBAYASHI Y, YAMAMOTO K, SAIDO T, et al. Identifica- tion of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha [J]. Proc Natl Acad Sci USA, 1990, (87) :5548-5552.
  • 10CHARLES A, DINARELLO. Interleukin-1 in the pathogenesis and treatment of in? ammatory diseases [ J]. Blood, 2011, 117(14) :3720-3732.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部